BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AV000103A (ICVAX) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AV000103A (ICVAX)\, from ClinicalTrials.g
 ov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07530198-1002@assetmemo.bio
DTSTAMP:20261121T005929Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:AV000103A (ICVAX): Phase 1 readout est. (NCT07530198)
DESCRIPTION:AV000103A (ICVAX)\, phase 1\, HIV.\nStudy: HIV Therapeutic DNA 
 Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong\nEstimated primary com
 pletion: 31 March 2027. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/av000103a-icvax#upcoming-events\nRegistry record: https://clinicaltrial
 s.gov/study/NCT07530198
URL:https://assetmemo.bio/drug/av000103a-icvax#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
